0001077183-21-000084.txt : 20210303
0001077183-21-000084.hdr.sgml : 20210303
20210303201823
ACCESSION NUMBER: 0001077183-21-000084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BALLIET JENNIFER
CENTRAL INDEX KEY: 0001640500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 21711962
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wf-form4_161482068265167.xml
FORM 4
X0306
4
2021-03-01
0
0001077183
NEOGENOMICS INC
NEO
0001640500
BALLIET JENNIFER
12701 COMMONWEALTH DRIVE SUITE 9
FORT MYERS
FL
33913
0
1
0
0
VP and Chief Culture Officer
Common Stock
2021-03-01
4
F
0
212
0
D
24768
D
Common Stock
2021-03-02
4
F
0
173
0
D
24595
D
Common Stock
2021-03-02
4
A
0
1862
0
A
26457
D
Stock Option (Right to Buy)
7.52
2022-04-28
Common Stock
7000.0
7000
D
Stock Option (Right to Buy)
8.03
2023-02-26
Common Stock
33334.0
33334
D
Stock Option (Right to Buy)
19.6
2024-03-01
Common Stock
17496.0
17496
D
Stock Option (Right to Buy)
28.33
2027-03-02
Common Stock
15006.0
15006
D
Stock Option (Right to Buy)
53.17
2021-03-02
4
A
0
10551
53.17
A
2028-03-02
Common Stock
10551.0
10551
D
Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.
On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.
On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date.
/s/Jennifer Balliet
2021-03-03